The Acute Myeloid Leukemia Therapeutics Market is expected to grow from an estimated USD 3.6 billion in 2024 to USD 9.4 billion in 2033, at a CAGR of 11.20%. The revenue growth of AML therapeutics can be attributed to increased spending by researchers to advance their understanding of the underlying genetic and molecular mechanisms driving AML. This includes the identification of...